Postoperative therapy with infliximab for Crohn’s disease: a 2-year prospective randomized multicenter study in Japan

[1] Rutgeerts P(1984)Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery Gut 25 665-672

[2] Geboes K(1991)Primary and recurrent Crohn’s disease. Experience with 1379 patients Ann Surg 214 230-238

[3] Vantrappen G(2006)European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations Gut 55 i36i58-963

[4] Kerremans R(1990)Predictability of the postoperative course of Crohn’s disease Gastroenterology 99 956-1623

[5] Coenegrachts JL(2009)Infliximab prevents Crohn’s disease recurrence after ileal resection Gastroenterology 136 44150 e1-1742

[6] Coremans G(2012)Scheduled infliximab monotherapy to prevent recurrence of Crohn’s disease following ileocolic or ileal resection: a 3-year prospective randomized open trial Inflamm Bowel Dis 18 1617-296

[7] Michelassi F(2013)Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial Am J Gastroenterol 108 1731-1221

[8] Balestracci T(2014)Impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn’s disease: a single-center paired case-control study Surg Today 44 291-149

[9] Chappell R(1976)Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study Gastroenterology 703 43944-1417

[10] Block GE(2008)The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies Int J Colorectal Dis 23 1213-1578

[1] Rutgeerts P(1984)Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery Gut 25 665-672

[2] Geboes K(1991)Primary and recurrent Crohn’s disease. Experience with 1379 patients Ann Surg 214 230-238

[3] Vantrappen G(2006)European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations Gut 55 i36i58-963

[4] Kerremans R(1990)Predictability of the postoperative course of Crohn’s disease Gastroenterology 99 956-1623

[5] Coenegrachts JL(2009)Infliximab prevents Crohn’s disease recurrence after ileal resection Gastroenterology 136 44150 e1-1742

[6] Coremans G(2012)Scheduled infliximab monotherapy to prevent recurrence of Crohn’s disease following ileocolic or ileal resection: a 3-year prospective randomized open trial Inflamm Bowel Dis 18 1617-296

[7] Michelassi F(2013)Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial Am J Gastroenterol 108 1731-1221

[8] Balestracci T(2014)Impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn’s disease: a single-center paired case-control study Surg Today 44 291-149

[9] Chappell R(1976)Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study Gastroenterology 703 43944-1417

[10] Block GE(2008)The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies Int J Colorectal Dis 23 1213-1578